German contract development and manufacturing company ProBioGen has announced the signing of a master service agreement (MSA) ...

Pheast Therapeutics is using a platform-based approach to scaling manufacturing for its anti-CD24 checkpoint inhibitor, PHST001. By compressing the chemistry, manufacturing, and control (CMC) steps ...

New contract reinforces Kincell Bio’s commitment to long-term partnerships to address development and GMP manufacturing support for engineered cellular therapies. DURHAM, N.C.--(BUSINESS ...

Microbial systems offer distinct advantages in protein expression, saving costs and time, and offering well-characterized host genetics and ease of scale-up. 2 However, challenges remain in process ...

GAINESVILLE, Fla.--(BUSINESS WIRE)--Kincell Bio, a cell therapy-focused cGMP contract development and manufacturing organization (CDMO), today announced that it has welcomed a new client for the ...

DURHAM, N.C., October 07, 2025--(BUSINESS WIRE)--Kincell Bio, a leading US cell therapy CDMO, is excited to announce a partnership with Moonlight Bio, Inc., a Seattle-based biotech company pioneering ...

GERMANTOWN, MD AND HOUSTON, TX / ACCESS Newswire / December 9, 2025 / uBriGene Biosciences, a global CDMO specializing in Advanced Therapy Medicinal Product (ATMP) GMP development and manufacturing, ...

BOSTON, Sept. 30, 2020 /PRNewswire/ -- Matrivax Research and Development Corporation has named Enda Moran, PhD, MBA, as vice president of process development and CMC. Dr. Moran will lead process ...

When navigating preliminary product development strategies, looking for early guidance from regulators can be invaluable. Even so, the task of seeking approval from the FDA can be extremely difficult.

GAINESVILLE, Fla., May 28, 2020 /PRNewswire/ -- Arranta Bio ("Arranta"), the leading microbiome contract development and manufacturing organization (CDMO), today announced completion of its process ...